CHRW
42
-5
APD
54
-3
PNW
66
-3
EMR
50
2
FLS
69
2
ROK
52
-2
CAT
61
-3
MRO
52
-2
EMN
48
-4
AMT
51
-4
TXN
53
3
ADI
56
2
AES
41
-2
KR
40
-6
AMAT
48
4
HIG
56
-3
PVH
59
6
AMZN
57
2
DE
46
-3
PHM
55
-5
CHRW
42
-5
APD
54
-3
PNW
66
-3
EMR
50
2
FLS
69
2
ROK
52
-2
CAT
61
-3
MRO
52
-2
EMN
48
-4
AMT
51
-4
TXN
53
3
ADI
56
2
AES
41
-2
KR
40
-6
AMAT
48
4
HIG
56
-3
PVH
59
6
AMZN
57
2
DE
46
-3
PHM
55
-5
Financhill
Back

Ultragenyx Pharmaceutical Quote, Financials, Valuation and Earnings

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.
Sell
46

RARE
Ultragenyx Pharmaceutical

Last Price:
52.02
Seasonality Move:
11.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Gold Set to Skyrocket as Fed Slashes Rates

Click here for the details on this incredible opportunity.

Ultragenyx Pharmaceutical Price Quote

$52.02
-0.78 (-1.48%)
(Updated: October 30, 2024 at 2:30 PM ET)

Ultragenyx Pharmaceutical Key Stats

Sell
46
Ultragenyx Pharmaceutical (RARE) is a Sell
Day range:
$52.38 - $53.48
52-week range:
$32.83 - $60.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.88
P/B ratio:
11.25%
Volume:
584.8K
Avg. volume:
594K
1-year change:
60.93%
Market cap:
$4.9B
Revenue:
$434.2M
EPS:
$-7.3

How Much Does Ultragenyx Pharmaceutical Make?

Is Ultragenyx Pharmaceutical Growing As A Company?

Ultragenyx Pharmaceutical Stock Price Performance

What Is Ultragenyx Pharmaceutical 52-Week High & Low?

Ultragenyx Pharmaceutical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ultragenyx Pharmaceutical?

Is Ultragenyx Pharmaceutical Cash Flow Positive?

  • What Is RARE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$469.5M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $740.7M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $112.3M

Ultragenyx Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    RARE return on invested capital is -290%
  • What Is Ultragenyx Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is -42%
  • What Is RARE Return On Equity?
    ROE is a measure of profitability and is -290%

Ultragenyx Pharmaceutical Earnings Date & Stock Price

Ultragenyx Pharmaceutical Competitors

Ultragenyx Pharmaceutical Dividend Yield

Ultragenyx Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.9%
Revenue: 35.75% 19.33%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 91.57
Upside from Last Price: 73.43%

Major Shareholders

  • How many RARE shares are owned by institutional investors?
    135.3M RARE shares are owned by institutional investors
  • How many RARE shares are owned by insiders?
    1.8M RARE shares are owned by insiders